Recent Advances of Circular RNAs as Biomarkers for Osteosarcoma

Hongliang Wu1,2,3, Sihang Zheng4, Qun He5

  • 1Department of Orthopedics, Fuzhou Second Hospital of Xiamen University, School of Medicine, Xiamen University, Xiamen, People's Republic of China.

Insights

Circular RNAs (ribonucleic acids) are key in osteosarcoma development and progression. Research into their mechanisms and clinical applications offers new avenues for early detection and improved treatment of this bone cancer.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Osteosarcoma is the most common primary malignant bone tumor in young adults.
  • It is characterized by early metastasis and a poor prognosis, necessitating improved treatment strategies.
  • Circular RNAs (circRNAs) are emerging as critical regulators in various diseases, including cancer.

Purpose of the Study:

  • To review the role of circRNAs in the occurrence and development of osteosarcoma.
  • To explore the clinical applications of circRNAs in osteosarcoma management.
  • To provide insights into circRNA-based diagnostic and therapeutic strategies for osteosarcoma.

Main Methods:

  • Literature review of recent studies on circRNAs in osteosarcoma.
  • Analysis of the molecular mechanisms underlying circRNA involvement in osteosarcoma.
  • Examination of current and potential clinical applications of circRNAs.

Main Results:

  • An increasing number of circRNAs have been identified in osteosarcoma tissues.
  • CircRNAs play significant roles in osteosarcoma proliferation, migration, invasion, and drug resistance.
  • Specific circRNAs show potential as diagnostic biomarkers and therapeutic targets for osteosarcoma.

Conclusions:

  • Understanding circRNA mechanisms is crucial for advancing osteosarcoma diagnosis and treatment.
  • CircRNAs represent promising targets for novel therapeutic interventions.
  • Further research is warranted to fully elucidate the clinical utility of circRNAs in osteosarcoma.

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.8K
lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
8.7K
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
5.3K
Tumor Progression02:07

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.4K